financetom
Market
financetom
/
Market
/
EaseMyTrip sells tickets worth Rs 350 crore in ten days, extends travel utsav sale till October 23
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
EaseMyTrip sells tickets worth Rs 350 crore in ten days, extends travel utsav sale till October 23
Oct 17, 2022 4:37 AM

Share Market Live

NSE

EaseMyTrip witnessed sales of over Rs 350 crore during its Travel Utsav Sale between October 6-16, Easy Trip Planners mentioned in an exchange filing.

Buoyed by the 'overwhelming' response, the company has extended the Travel Utsav Sale till October 23.

Previously, EaseMyTrip had sold tickets worth Rs 300 crore in the first 10 days of August as part of its Annual Festive Season Sale.

EaseMyTrip is offering discounts of up to 14 percent and 10 percent on domestic and international flights, respectively. It also offers discounts on bus tickets and hotel bookings. Holiday and cruise packages are also offered at discounted rates.

“We hope to see more travellers benefiting from our extended sale and to keep travelling with us to meet their loved ones during the festivals,” Co-Founder and CEO Nishant Pitti was quoted as saying.

Last week, the company announced the launch of the Save Now Buy Later (SNBL) product. This is an investment scheme that allows customers to start a Systematic Investment Plan (SIP) for their travel plans.

The investment scheme can be availed for a minimum of 90 days. For domestic travellers, upon successful completion of 90 days, the collected amount can be redeemed to book a holiday package or a hotel stay of choice anytime on EaseMyTrip.

Last week, the company's board also approved a 2:1 stock split as well as announced the issue of three bonus shares for every one share held by investors.

Shares of Easy Trip Planners are trading at Rs 392.75, up 1.05 percent, as of 1:30 PM.

(Edited by : Rukmani Krishna)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Oil Prices Rise on Fears of a Widening Mideast War While the IEA Lowers its Demand Forecast
Oil Prices Rise on Fears of a Widening Mideast War While the IEA Lowers its Demand Forecast
Apr 12, 2024
08:51 AM EDT, 04/12/2024 (MT Newswires) -- Oil prices rose early on Friday, supported by fears of a widening Middle East war as Iran is said to be readying a retaliatory attack on Israel even as the International Energy Agency lowered its demand forecast for this year. West Texas Intermediate crude oil for May delivery was last seen up US$1.39...
US STOCKS-Wall St set for lower open as some big bank earnings disappoint
US STOCKS-Wall St set for lower open as some big bank earnings disappoint
Apr 12, 2024
(For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window) * Wells Fargo ( WFC ) falls after Q1 profit drop * JPMorgan Chase & Co ( JPM ) down after NII forecast miss * Futures down: Dow 0.29%, S&P 0.38%, Nasdaq 0.51% (Updated at 8:30 a.m. ET/ 1230 GMT)...
Sector Update: Tech
Sector Update: Tech
Apr 12, 2024
08:48 AM EDT, 04/12/2024 (MT Newswires) -- Technology stocks were mixed premarket Friday with the Technology Select Sector SPDR Fund (XLK) down 0.7% and the SPDR S&P Semiconductor ETF (XSD) was 2.3% higher recently. Richtech Robotics ( RR ) was up 0.4% after saying it has formed a joint venture with Zipphaus to launch a series of robot-operated cafes in...
Sector Update: Health Care
Sector Update: Health Care
Apr 12, 2024
08:54 AM EDT, 04/12/2024 (MT Newswires) -- Health care stocks were steady premarket Friday, with the Health Care Select Sector SPDR Fund (XLV) and iShares Biotechnology ETF (IBB) both inactive. Nurix Therapeutics ( NRIX ) stock was down nearly 5% after the company said overnight it priced an underwritten public offering of 10.2 million common shares at $15 apiece for...
Copyright 2023-2026 - www.financetom.com All Rights Reserved